Otto Pharmaceutical Industries

What Otto Pharmaceutical Industries does

PT. Otto Pharmaceutical Industries is an Indonesian pharmaceutical manufacturer founded in 1963 in Bandung, West Java, and acquired by Mensa Group in 1981. The company produces a broad portfolio of generic and non-generic pharmaceutical products across 13+ therapeutic categories, including antibiotics (betalactam/cephalosporin, quinolones, macrolides, aminoglycosides), respiratory medications, gastrointestinal drugs, cardiovascular and antidiabetic agents, central nervous system drugs, analgesics, hormones, dermatological products, vitamins, and bone & joint supplements. Its product portfolio spans approximately 90+ SKUs with various formulations including tablets, capsules, syrups, injectables, and topical preparations.

Manufacturing operations are conducted at two separate cGMP-compliant facilities in Bandung: a Non-Betalactam plant (producing tablets, capsules, syrups, and injectable solutions) and a Cephalosporin plant (producing capsules, dry syrups, and injectable powder). The facilities span over 20,000 sqm of production area, designed by NNE Pharmaplan to meet PIC/S and EU standards, with annual capacity in the hundreds of millions of units. The company holds CPOB certification (1991), ISO 9001:2015 certification (2018), and PIC/S compliance.

Otto distributes products through a professional sales force of over 600 medical representatives and field managers covering more than 150 cities across Indonesia. The go-to-market model is sales-led, with representatives providing scientific information and medical evidence to healthcare providers. The company is exploring contract manufacturing and co-marketing partnerships, and has expanded into Asia Pacific regional markets through Mensa Group's international operations. Otto is a privately held subsidiary of Mensa Group, a diversified Indonesian conglomerate.

Name

Otto Pharmaceutical Industries

Legal name

PT. Otto Pharmaceutical Industries

Website

https://ottopharm.com

Company type

Private

Founded year

1963

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

PT. Otto Pharmaceutical Industries is an Indonesian generic and non-generic pharmaceutical manufacturer founded in 1963, producing antibiotics, cardiovascular drugs, antidiabetics, and other therapeutic categories, distributing to healthcare providers across 150+ Indonesian cities via 600+ medical representatives.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• Antibiotic production
• Cephalosporin injectables
• Cardiovascular drugs

Headquarters

HQ city

Jakarta

HQ country

Indonesia

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and selling generic and non-generic pharmaceutical products including antibiotics, respiratory medicines, cardiovascular drugs, antidiabetic agents, analgesics, and vitamins. Products are distributed through professional sales force to healthcare providers across Indonesia.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

PT. Otto Pharmaceutical Industries manufactures and distributes a broad portfolio of generic and non-generic pharmaceutical products across multiple therapeutic categories including antibiotics, respiratory medications, gastrointestinal drugs, cardiovascular drugs, antidiabetics, analgesics, vitamins and bone & joint supplements. Products are produced in two cGMP-compliant facilities (Non-Betalactam and Cephalosporin plants) in tablets, capsules, syrups, injectables (solution and powder), and topical forms. The company sells primarily through a professional sales force of more than 600 medical representatives reaching healthcare providers across 150+ cities in Indonesia.

Product overview

PT. Otto Pharmaceutical Industries is a pharmaceutical manufacturing company producing a comprehensive portfolio of quality generic and non-generic medicines. The company's product portfolio spans multiple therapeutic categories including: antibiotics (betalactam/cephalosporin, quinolone, macrolide, aminoglycoside, lincosamide, metronidazole), respiratory medications (cough & cold remedies, anti-asthmatics, mucolytics), gastrointestinal drugs (antacids, anti-emetics, digestive enzymes, laxatives, antidiarrheals), allergy and immune system treatments, cardiovascular and hematopoietic medications (vasodilators, calcium antagonists, beta blockers), antidiabetic agents, central nervous system drugs (anticonvulsants, anxiolytics), neuromuscular medications (analgesics, NSAIDs, anti-inflammatory), hormones (corticosteroids), dermatological products (topical corticosteroids, anti-infectives, antifungals), mouth/throat preparations, vitamins and minerals, and bone & joint supplements. The company operates manufacturing facilities for tablets, capsules, syrups/liquids, injectables (powder and solution), and topical preparations, distributing to over 150 cities throughout Indonesia with more than 600 medical representatives.

Differentiator

Problem solved

Functional benefit

Products and services

• Antibiotic Product Line Comprehensive portfolio of antibiotics including betalactams (Amoxycillin, Amoxycillin+Clavulanic Acid), cephalosporins across first through fourth generations (Cefadroxil, Cefotaxime, Ceftriaxone, Ceftazidime, Cefoperazone, Cefpirome, Cefepime, Cefoperazone+Sulbactam), carbapenems (Meropenem), fluoroquinolones (Ciprofloxacin, Levofloxacin, Moxifloxacin), macrolides (Erythromycin, Spiramycin, Azithromycin), aminoglycosides (Gentamycin), anti-protozoals (Metronidazole, Metronidazole+Nystatin), lincosamides (Lincomycin, Clindamycin), and other classes (Thiamphenicol). Available in capsules, tablets, dry syrups, injections, and infusions for treatment of bacterial, protozoal, and associated infections.
• Respiratory Medicines (Cough, Cold, Anti-Asthmatic, Mucolytic) Respiratory product line covering cough and cold remedies (Dextrosin variants, Fluzep), antihistamine/decongestant combinations (Trifedrin, Trifedrin Plus, Trifedrin Cum Exp), bronchodilators (Nairet / Terbutaline), and mucolytics (Mucera / Ambroxol). Available in tablet, capsule, syrup, and injection forms for treatment of upper respiratory tract infections, asthma, and congestion.

Quantifiable outcome

• Established April 8, 1963; acquired by Mensa Group in 1981; CPOB certified in 1991; ISO 9001 certified since 2005

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Mensa GroupcoreOthersMensa Group is the parent company of PT. Otto Pharmaceutical Industries. OTTO was established on April 8, 1963, and ownership was taken over by Mensa Group in 1981. The group supports OTTO's expansion, manufacturing development, and human resource development. Mensa Group also provides shared services including corporate headquarters in Jakarta and career portal for recruitment.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Kalbe Farma: Indonesia's largest pharmaceutical manufacturer with a broad generic, consumer health, and distribution portfolio. Directly comparable to Otto as a domestic Indonesian pharma manufacturer serving similar healthcare providers with overlapping therapeutic categories.
• Dexa Medica: Major Indonesian pharmaceutical group with branded generics, APIs, and a strong medical representative salesforce. Closely comparable to Otto in scale, product mix, and Indonesian distribution model.
• Sanbe Farma: Indonesian pharmaceutical manufacturer producing generics across multiple therapeutic categories including antibiotics and cardiovascular. Direct competitor with similar production footprint and hospital channel focus.
• Tempo Scan Pacific: Listed Indonesian pharmaceutical and consumer health company with branded generics and OTC products. Comparable therapeutic breadth and Indonesian salesforce-driven distribution model to Otto.
• Kimia Farma: State-owned Indonesian pharmaceutical manufacturer and pharmacy operator with broad generic portfolio. Comparable manufacturing footprint and serves similar healthcare provider and institutional channels as Otto.
• Pharos Indonesia: Indonesian pharmaceutical company producing branded generics across cardiovascular, antibiotics, and other primary care categories. Directly comparable to Otto in scale, therapeutic mix, and domestic distribution approach.
• Indofarma: Indonesian state-listed pharmaceutical manufacturer with generic and branded pharmaceutical products in similar therapeutic areas. Directly comparable in product categories and institutional customer base to Otto.
• Meprofarm: Indonesian pharmaceutical manufacturer focused on generics and branded products across multiple therapeutic categories. Comparable mid-size Indonesian pharma manufacturer serving healthcare providers through a professional salesforce.

Regional players

• Hovid Berhad: Malaysian pharmaceutical manufacturer with a broad generic portfolio across antibiotics, cardiovascular, and OTC categories. Comparable in manufacturing scale and product breadth but operates primarily in Malaysian and Southeast Asian markets rather than Indonesia directly.

Broad incumbents

• Mylan (now Viatris): Global generic and specialty pharmaceutical major with presence across Southeast Asia. Comparable as a broad generic manufacturer but operates at much larger scale and with global portfolio breadth rather than Indonesian-focused distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/trainingmrotto
• Facebookfacebook.com/OTTO-Pharmaceutical-100064081743850
• LinkedInlinkedin.com/company/pt-otto-pharmaceutical-industries-ltd

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Otto Pharmaceutical Industries